Skip to main content

ORIGINAL RESEARCH article

Front. Aging Neurosci.
Sec. Alzheimer's Disease and Related Dementias
Volume 16 - 2024 | doi: 10.3389/fnagi.2024.1432357
This article is part of the Research Topic Cognition, Neurodegeneration and Immunity: from Observational Data to Molecular Mechanisms View all 5 articles

Age-dependent phenotypes of cognitive impairment as sequelae of SARS-CoV-2 infection

Provisionally accepted
  • 1 The University of Texas Health Science Center at San Antonio, San Antonio, United States
  • 2 Facultad de Psicología y Psicopedagogía, Universidad Católica Argentina, Buenos Aires, Buenos Aires, Argentina
  • 3 Department of Neurology, Medical School, University of Cyprus, Nicosia, Nicosia, Cyprus
  • 4 Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
  • 5 Tanz Centre for Research on Neurodegenerative Diseases, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
  • 6 Memory Clinic, Krembil Brain Institute, University Health Network (UHN), Toronto, Canada
  • 7 IQRAA International Hospital and Research Centre, Kozhikode, Kerala, India
  • 8 Moscow Research and Clinical Center for Neuropsychiatry, Moscow, Moscow Oblast, Russia
  • 9 Pirogov Russian National Research Medical University, Moscow, Moscow Oblast, Russia
  • 10 Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
  • 11 Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, England, United Kingdom
  • 12 Neurology Unit, Mediterranean Institute for Transplantation and Highly Specialized Therapies (ISMETT), Palermo, Italy
  • 13 University of Pittsburgh Medical Center, Palermo, Italy
  • 14 División de Salud Pública y Medicina Familiar, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Santiago Metropolitan Region (RM), Chile
  • 15 School of Psychology and Sport Science, Bangor University, Bangor, United Kingdom
  • 16 Secretariat for Mental Health and Addictions, Ministry of Health, Government of Jujuy, San Salvador de Jujuy, Argentina
  • 17 San Lazaro Institute of Neurosciences, Foundation to Fight Neurological and Psychiatric Disorders in Minorities, San Salvador de Jujuy, Argentina
  • 18 Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, United Kingdom
  • 19 Pontifical Catholic University of Argentina, Buenos Aires, Argentina
  • 20 Department of Psychiatry, School of Medicine, Indiana University Bloomington, Suite, United States
  • 21 Indiana Alzheimer Disease Center, School of Medicine, Indiana University Bloomington, Indianapolis, Indiana, United States
  • 22 Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, England, United Kingdom
  • 23 Cardiff University, Cardiff, United Kingdom
  • 24 Faculty of Medicine, The University of Tokyo, Bunkyo, Tōkyō, Japan
  • 25 Centre for Healthy Ageing, Health Futures Institute, Murdoch University, Murdoch, Australia
  • 26 University of Leicester, Leicester, East Midlands, United Kingdom

The final, formatted version of the article will be published soon.

    Cognitive changes associated with PASC may not be uniform across populations. We carried out individual-level pooled analyses and meta-analysis of cognitive assessments from 8 prospective cohorts including 2105 patients and 1432 controls from Argentina, Canada, Chile, Greece, India, Italy, Russia and the UK. Meta-analysis found no differences by country of origin. Profile and severity of cognitive impairment differed by age with mild attentional impairment in young and middle-aged adults, but memory, language and executive function impairment in older adults. Risk of moderate to severe impairment was doubled in older adults. Moderately severe or severe impairment was significantly associated with infection diagnoses (chi-square = 26.57, p-value =<0.0001) and with severity of anosmia (chi-square = 31.81, p-value =<0.0001). We found distinct age-related phenotypes of cognitive impairment in patients recovering from COVID-19 and identified severity of acute illness and presence of olfactory dysfunction were the primary predictors of dementia-like impairment in older adults.

    Keywords: COVID - 19, cognitive decline, International cohort, Age dependent, Long Covid

    Received: 13 May 2024; Accepted: 28 Oct 2024.

    Copyright: © 2024 de Erausquin, Gonzalez Alemán, Vavougios, Tartaglia, Uvais, Guekht, Hosseini, Lo Re, Ferreccio, D'Avossa, Zamponi, Figueredo Aguiar, Yecora, Ul Haq Katshu, Stavrou, BOUTLAS, Gourgoulianis, Botero, González Insúa, López Llobet, Zinchuk, Gersamija, Popova, Bryzgalova, Sviatskaia, Russelli, Avorio, Wang, Edison, NIIMI, Sohrabi, Mukaetova-Ladinska and Neidre. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Gabriel A. de Erausquin, The University of Texas Health Science Center at San Antonio, San Antonio, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.